Relevant Disclosure is attached.
Awaiting price reaction for this filing.
Fortis Healthcare's Board of Directors, at a meeting held on May 20, 2025, approved revisions to two key governance policies. The first is the Policy on Related Party Transactions (now Version 8.0), which lays down the framework for approval, review, and reporting of transactions with related parties as required under SEBI Listing Regulations. The second is the Policy/Code of Conduct for Prevention of Insider Trading (now Version 7), which governs trading in company securities by designated persons and insiders to prevent misuse of unpublished price-sensitive information (UPSI). Both policies have been reviewed and updated to align with current SEBI regulations, including provisions on structured digital databases, trading windows, and disclosure requirements. The Board meeting concluded at 18:55 hours IST on May 20, 2025.
This is a routine regulatory compliance update with no direct financial impact on shareholders. The revised policies strengthen corporate governance around related party transactions and insider trading, which is positive for transparency and investor protection but unlikely to move the stock price.